Expanding our knowledge
of cell therapy manufacturing

OUR CAPABILITIES

Reliable partner for cell & gene therapy manufacturing

As a long-term manufacturing partner, we will strategically guide our business partners through every step of the cell therapy manufacturing chain. We offer full services covering GMP production of Advanced Therapy Medicinal Products including genetically modified and viral vectors. SCTbio leverages a decade of experience
in development of autologous cell-based products, product supply for clinical trials, GMP compliance for the full lifecycle of drug development, manufacturing, quality control, QA/QP release, storage and logistics services and process development services to deliver the highest quality collaboration for your CDMO needs. 

History of SCTbio

SCTbio was formed on July 1, 2021, and is a part of PPF Biotech network. The key company and personnel capabilities have been generated within SOTIO Group, during its more than 10 years of history of drug development and manufacturing. All of SOTIO’s cell and gene therapy GMP manufacturing capabilities have been outsourced to SCTbio, including our GMP manufacturing facility in Prague, Czech Republic. 

12  years

in cell and gene therapy field

2.000 sqm

facility area including 420sqm of GMP clean rooms 

80+

reliable team members

Our Team


Pascale Charbonnel 

Business Development Representative
[email protected]

“SCTbio already had an impressive track record of experience with autologous cell therapy manufacturing, including not just GMP manufacturing and analytical capabilities, but a sophisticated cold chain operation, scheduling and supply chain software, and extensive network of qualified leukapheresis sites.”
Geoffrey Hodge CEO SOTIO Biotech Inc.

Cambridge

SOTIO Biotech Inc.
200 Cambridgepark Drive, Suite 3100,
Cambridge, MA 02140
USA

Prague

SCTbio a.s.
Jankovcova 2,
170 00 Prague 7
Czech Republic